AN2 Therapeutics, Inc. (ANTX) insider trading

By person

18 insiders · 140 transactions

14.3×

Eric Easom holds 14.3 times base salary in stock. $8.64M of shares against $603.75K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Easom last reported holding, valued at $6.02, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

10% owner

$41.84M (10)

$3.81M (2)

+$38.04M

300,853

0.7973%

$1.81M

—

Robin Shane Readnour

Director

$2.71M (16)

$428.37K (12) scheduled

+$2.28M

1,267,709

3.36%

$7.64M

+1,559%

Joseph S Zakrzewski

Director

$27.85K (3)

$1.91M (1)

−$1.88M

145,538

0.3857%

$876.76K

−71.2%

Braden Michael Leonard

10% owner

$1.56M (1)

$3.09M (5)

−$1.53M

3,217,432

8.53%

$19.38M

−27.7%

Adjuvant Global Health Technology Fund, L.P. entity

10% owner

$2.50M (1)

$3.98M (20)

−$1.48M

2,373,500

6.29%

$14.30M

—

Kabeer Aziz

Director

$2.50M (1)

$3.98M (20)

−$1.48M

816,655

2.16%

$4.92M

—

Eric Easom

Chief Executive Officer

$114.41K (3)

$1.55M (23)

−$1.44M

1,434,396

3.80%

$8.64M

+30.4%

Kevin Michael Krause

Chief Strategy Officer

—

$201.33K (2) scheduled

−$201.33K

31,914

0.0846%

$192.26K

+1,567%

Joshua M Eizen

See Remarks

—

$65.94K (5)

−$65.94K

206,554

0.5474%

$1.24M

+941.4%

Margaret M FitzPatrick

Director

$21.74K (2)

—

+$21.74K

10,708

0.0284%

$64.51K

—

Sanjay Chanda

Chief Development Officer

—

$13.30K (3)

−$13.30K

118,823

0.3149%

$715.83K

+677.6%

Lucy Day

Chief Financial Officer

—

$12.85K (3)

−$12.85K

118,363

0.3137%

$713.05K

+553.0%

Stephen David Prior

Chief Strategy Officer

—

$10.10K (4)

−$10.10K

59,086

0.1566%

$355.95K

+95.5%

Sarah Joanne Williams

Principal Accounting Officer

—

$3.02K (3)

−$3.02K

66,311

0.1757%

$399.48K

+252.7%

Cameron C. Trenor III

Chief Medical Officer

—

116,667

0.3092%

$702.84K

—

Gilbert Lynn Marks

Director

—

84,156

0.2230%

$506.98K

+268.6%

Paul Eckburg

Chief Medical Officer

—

51,416

0.1363%

$309.75K

+140.1%

Patricia A. Martin

Director

—

19,252

0.0510%

$115.98K

—

AN2 Therapeutics, Inc.

What the insiders did Net buying

By person